Wong Ka H, Razmovski-Naumovski Valentina, Li Kong M, Li George Q, Chan Kelvin
Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia.
Faculty of Pharmacy, The University of Sydney, NSW 2006, Australia; National Institute of Complementary Medicine, University of Western Sydney, NSW 2560, Australia.
J Ethnopharmacol. 2015 Apr 22;164:53-63. doi: 10.1016/j.jep.2014.12.050. Epub 2015 Jan 2.
Puerariae Lobatae Radix (PLR) and Puerariae Thomsonii Radix (PTR) are traditional Chinese medicines used for the treatment of diabetes and cardiovascular diseases. These two herbs are used interchangeably in clinical practice, even though they possess significantly different chemical profiles. In the case of Pueraria species, the misidentification is related to the multiple Chinese common names in clinical practice and variable pharmaceutical Latin names in different versions of the Pharmacopoeia of the People's Republic of China. In addition, there is lack of evidence demonstrating how the differences in the chemical profile would impact on the pharmacological activity of the two herbs. Therefore, the aim of this study was to compare the microscopic, phytochemical profiles and anti-diabetic activity of PLR and PTR so that the two species can be differentiated.
The microscopic characteristics of the PLR and PTR were observed and measured by an optical microscope. The major compounds were quantified by ultra-performance liquid chromatography (UPLC) and total flavonoid content (TFC) colorimetric assay. The free radical scavenging capacity was assessed by 2,2-diphenyl-2-picrylhydrazyl (DPPH) antioxidant assays. Anti-diabetic activity was determined by the inhibition of porcine pancreatic α-amylase and rat intestinal α-glucosidase activities.
Microscopic results illustrated that the size of xylem vessels (PLR: 0.1390 ± 0.0184 mm; PTR: 0.0471 ± 0.0109 mm), number of fibre per bundle (PLR: 32.6800 ± 2.8780; PTR: 16.5900 ± 0.9982) and the size of fibre (PLR: 0.0075 ± 0.0003 mm(2); PTR: 0.0025 ± 0.0002 mm(2)) in PLR were significantly greater than that in PTR (p<0.01). PLR possessed a significantly lower total starch content (PLR: 0.5288 ± 1.2559 mg starch/g DM; PTR: 76.7954 ± 2.9905 mg starch/g DM) and total dietary fibre content (PLR: 4.2886 ± 0.3466 g/100g DM; PTR: 12.4148 ± 0.4541 g/100g DM) as compared to PTR. Isoflavonoids including puerarin, daidzin, genistin and daidzein were the major chemical constituents in both species. However, the average content of puerarin in PLR was found to be eleven times greater than that in PTR. Furthermore, the TFC, DPPH free radical scavenging capacity, anti-α-amylase and anti-α-glucosidase in the PLR extracts were 4.42, 4.91, 3.10 and 4.22 times greater than in the PTR extracts.
This study provides a comprehensive investigation on the two medicinal valuable Pueraria species and allows differences to be ascertained. This information can be used to update monographs which will help practitioners and dispensers differentiate the herbs. Further study on the interchangeable use of PLR and PTR in clinical practice is urgently warranted.
葛根(PLR)和粉葛(PTR)是用于治疗糖尿病和心血管疾病的传统中药。这两种草药在临床实践中可互换使用,尽管它们的化学组成有显著差异。就葛根属植物而言,误认与临床实践中的多个中文通用名以及《中华人民共和国药典》不同版本中多变的药用拉丁名有关。此外,缺乏证据表明化学组成的差异会如何影响这两种草药的药理活性。因此,本研究的目的是比较葛根和粉葛的微观特征、植物化学特征及抗糖尿病活性,以便区分这两个物种。
通过光学显微镜观察和测量葛根和粉葛的微观特征。主要化合物通过超高效液相色谱(UPLC)和总黄酮含量(TFC)比色法进行定量。通过2,2 - 二苯基 - 2 - 苦基肼(DPPH)抗氧化试验评估自由基清除能力。通过抑制猪胰腺α - 淀粉酶和大鼠肠道α - 葡萄糖苷酶活性来测定抗糖尿病活性。
微观结果表明,葛根木质部导管大小(PLR:0.1390±0.0184毫米;PTR:0.0471±0.0109毫米)、每束纤维数量(PLR:32.6800±2.8780;PTR:16.5900±0.9982)以及纤维大小(PLR:0.0075±0.0003平方毫米;PTR:0.0025±0.0002平方毫米)均显著大于粉葛(p<0.01)。与粉葛相比,葛根的总淀粉含量(PLR:0.5288±1.2559毫克淀粉/克干物质;PTR:76.7954±2.9905毫克淀粉/克干物质)和总膳食纤维含量(PLR:4.2886±0.3466克/100克干物质;PTR:12.4148±0.4541克/100克干物质)显著更低。异黄酮类化合物包括葛根素、大豆苷、染料木苷和大豆苷元是这两个物种的主要化学成分。然而,发现葛根中葛根素的平均含量比粉葛高11倍。此外, 葛根提取物中的TFC、DPPH自由基清除能力、抗α - 淀粉酶和抗α - 葡萄糖苷酶活性分别是粉葛提取物的4.42、4.91、3.10和4.22倍。
本研究对两种具有药用价值的葛根属植物进行了全面研究,并确定了它们之间的差异。这些信息可用于更新专著,这将有助于从业者和药剂师区分这些草药。迫切需要对葛根和粉葛在临床实践中的互换使用进行进一步研究。